Pharmacological characterization of the beta-adrenoceptor that mediates the relaxant response to noradrenaline in guinea-pig tracheal smooth muscle

Naunyn-Schmiedeberg's Archives of Pharmacology
Y TanakaK Koike


Pharmacological characteristics of beta-adrenoceptors (beta-ARs) mediating noradrenaline-induced relaxation were investigated in guinea-pig tracheal smooth muscle. The inhibitory effects of several types of beta-AR antagonists on noradrenaline-induced relaxation against histamine contraction were scrutinized with Schild plot analysis. The concentration-response curve for noradrenaline obtained in the absence of phentolamine and uptake inhibitors was competitively antagonized by all of the beta-AR antagonists used in this study (propranolol, bupranolol, atenolol, butoxamine and ICI-118,551). However, their pA2 values were markedly less than the expected values for beta1-AR and beta2-AR. On the other hand, pA2 values of ICI-118,551 (6.85) determined in the presence of phentolamine suggested a contribution of a beta1 -AR rather than beta2 -AR. In the presence of phentolamine and uptake inhibitors (desipramine and deoxycorticosterone), the Schild plot for atenolol was a better fit, with two distinct straight lines. The pA2 values of atenolol provided by the regression were: approximately 7.0, which corresponds to the expected beta1-AR value, and approximately 6.5, which was 3 times less than the expected value for beta1 -AR, and th...Continue Reading


Jul 17, 1990·European Journal of Pharmacology·I TakayanagiK Koike
Jan 1, 1990·British Journal of Pharmacology·P J Henry, R G Goldie
Feb 1, 1970·The American Journal of Physiology·J H FleischB B Brodie
Sep 1, 1981·Journal of Autonomic Pharmacology·S R O'Donnell, J C Wanstall
May 4, 1984·European Journal of Pharmacology·C WilsonJonathan R S Arch
Oct 1, 1994·Trends in Pharmacological Sciences·T J Torphy
Nov 1, 1993·Medicinal Research Reviews·Jonathan R S Arch, A J Kaumann
Jan 1, 1993·Life Sciences·F P Nijkamp
Nov 17, 1998·American Journal of Respiratory and Critical Care Medicine·M Johnson
Dec 10, 1999·Journal of Autonomic Pharmacology·S M MustafaM A Oriowo
Jun 18, 2002·European Journal of Pharmacology·Bertil Waldeck
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Jun 25, 2004·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Y TanakaK Koike
Oct 30, 2004·British Journal of Pharmacology·Jonathan R S Arch
Jul 12, 2005·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Y TanakaK Koike


Jun 13, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Martin C Michel, Sergio Parra
Oct 4, 2011·Journal of Receptor and Signal Transduction Research·Y TanakaY Kasuya
Mar 16, 2018·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Daisuke ChinoY Tanaka
Feb 18, 2011·British Journal of Pharmacology·J Daniel HothersallJames R Baker

Related Concepts

ICI 118551, hydrochloride
1-(2-((3-carbamoyl-4-hydroxy)phenoxy)ethylamino)-3-(4-(1-methyl-4-trifluoromethyl-2-imidazoylyl)phenoxy)-2-propanol methanesulfonate
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Butoxamine Hydrochloride

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.